An Open Label Phase I Dose Escalation Study of E7080 Administered to Patients With Solid Tumors

Clinical trial NCT00280397 · COMPLETED

Trial details

NCT number: NCT00280397
Sponsor: Eisai Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cancer: Solid Tumors

Start date: 2006-01-01
Primary completion: 2008-09-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.